The data forecasts an increasing trend in mortality due to liver malignant neoplasms in the UK from 2024, with rates rising from 7.14 to 7.96 thousand deaths by 2028. Based on past data, the figures for 2023 are not provided, but the upward trajectory indicates an escalating health concern. The year-on-year variation shows a consistent incremental rise, highlighting an approximate increase of 2.8% annually towards the end of the forecasted period, while the cumulative average growth rate (CAGR) suggests a significant 5-year trend of rising death rates.
Future trends to watch include advancements in healthcare technology, policy changes, and lifestyle-related risk factors that could influence mortality rates. Observing these developments will be crucial for understanding the broader implications on public health strategies and resource allocation.
